1. A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient. Issue 1 (24th November 2019) Authors: Fujioka, Yutaka; Hata, Nobuhiro; Hatae, Ryusuke; Suzuki, Satoshi O.; Sangatsuda, Yuhei; Nakahara, Yukiko; Mizoguchi, Masahiro; Iihara, Koji Journal: Neuropathology Issue: Volume 40:Issue 1(2020) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of ganglioglioma grade 3 with H3 K27M mutation arising in the medial temporal lobe in an elderly patient. Issue 3 (20th February 2022) Authors: Fujii, Yutaro; Hatae, Ryusuke; Hata, Nobuhiro; Suzuki, Satoshi O.; Sangatsuda, Yuhei; Takigawa, Kosuke; Funakoshi, Yusuke; Fujioka, Yutaka; Kuga, Daisuke; Mizoguchi, Masahiro; Iwaki, Toru; Yoshimoto, Koji Journal: Neuropathology Issue: Volume 42:Issue 3(2022) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A juvenile case of epilepsy‐associated, isocitrate dehydrogenase wild‐type/histone 3 wild‐type diffuse glioma with a rare BRAFA598T mutation. Issue 6 (29th September 2020) Authors: Sadashima, Shoko; Suzuki, Satoshi O.; Haruyama, Hironori; Mukae, Nobutaka; Fujioka, Yutaka; Hata, Nobuhiro; Mizoguchi, Masahiro; Ishimatsu, Keisuke; Hiwatashi, Akio; Iwaki, Toru Journal: Neuropathology Issue: Volume 40:Issue 6(2020) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application. (28th November 2020) Authors: Funakoshi, Yusuke; Hata, Nobuhiro; Kuga, Daisuke; Hatae, Ryusuke; Sangatsuda, Yuhei; Fujioka, Yutaka; Takigawa, Kosuke; Mizoguchi, Masahiro Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 3 Page Start: ii7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACT-16 THE POTENTIAL OF HYPOFRACTIONATED RADIOTHERAPY AND BEVACIZUMAB FOR GLIOBLASTOMA TREATMENT. (16th December 2019) Authors: Hata, Nobuhiro; Mizoguchi, Masahiro; Kuga, Daisuke; Hatae, Ryusuke; Sangatsuda, Yuhei; Akagi, Yojiro; Amemiya, Takeo; Fujioka, Yutaka; Takigawa, Kosuke; Yoshitake, Tadamasa; Yoshimoto, Koji; Iihara, Koji Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 2 Page Start: ii15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical outcomes after craniotomy for unruptured intracranial aneurysm in patients with coronary artery disease. (December 2017) Authors: Nakamizo, Akira; Amano, Toshiyuki; Matsuo, Satoshi; Michiwaki, Yuhei; Fujioka, Yutaka; Kawano, Yousuke Journal: Journal of clinical neuroscience Issue: Volume 46(2017:Dec.) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. (10th April 2021) Authors: Funakoshi, Yusuke; Hata, Nobuhiro; Takigawa, Kosuke; Arita, Hideyuki; Kuga, Daisuke; Hatae, Ryusuke; Sangatsuda, Yuhei; Fujioka, Yutaka; Sako, Aki; Umehara, Toru; Yoshitake, Tadamasa; Togao, Osamu; Hiwatashi, Akio; Yoshimoto, Koji; Iwaki, Toru; Mizoguchi, Masahiro Journal: Cancer medicine Issue: Volume 10:Number 10(2021) Page Start: 3177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MPC-06 Cutting-edge of Cancer Genomic Medicine for brain tumors. (28th November 2020) Authors: Mizoguchi, Masahiro; Hata, Nobuhiro; Kuga, Daisuke; Hatae, Ryusuke; Sangatsuda, Yuhei; Fujioka, Yutaka; Takigawa, Kosuke; Funakoshi, Yusuke; Koga, Yuhki Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 3 Page Start: ii12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pediatric glioblastoma with oligodendroglioma component: Aggressive clinical phenotype with distinct molecular characteristics. Issue 6 (27th March 2013) Authors: Mizoguchi, Masahiro; Hata, Nobuhiro; Suzuki, Satoshi O.; Fujioka, Yutaka; Murata, Hideki; Amano, Toshiyuki; Nakamizo, Akira; Yoshimoto, Koji; Iwaki, Toru; Sasaki, Tomio Journal: Neuropathology Issue: Volume 33:Issue 6(2013) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Surgical outcome in elderly patients with intracranial meningioma. (October 2018) Authors: Amano, Toshiyuki; Nakamizo, Akira; Michiwaki, Yuhei; Matsuo, Satoshi; Fujioka, Yutaka; Nagata, Shinji Journal: Journal of clinical neuroscience Issue: Volume 56(2018) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗